Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to <it>Mycobacterium tuberculosis</it>: a pilot study

Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to <it>Mycobacterium tuberculosis</it>: a pilot study

<p>Abstract</p> <p>Rationale</p> <p>Existing data on the effect of treatment of latent tuberculosis infection (LTBI) on T-cell responses to <it>Mycobacterium tuberculosis </it>(MTB)-specific antigens are contradictory. Differences in technical aspects of the...

Full description

Bibliographic Details
Main Authors:	Ippolito Giuseppe, Nisii Carla, Anzidei Gianfranco, Dainotto Duilio, Casetti Rita, Bizzoni Federica, Butera Ornella, Parracino M Pasquale, Goletti Delia, Poccia Fabrizio, Girardi Enrico
Format:	Article
Language:	English
Published:	BMC 2007-01-01
Series:	Respiratory Research
Online Access:	http://respiratory-research.com/content/8/1/5

Similar Items

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response
by: Laurenti Patrizia, et al.
Published: (2009-11-01)

IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy
by: Girardi Enrico, et al.
Published: (2011-05-01)

Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.
by: Giovanni Delogu, et al.
Published: (2011-01-01)

Comparative analysis of the effectiveness of tuberculosis prophylaxis in patients with HIV/AIDS treated with isoniazid
by: Konrad Juszkiewicz, et al.
Published: (2019-09-01)

Does an isoniazid prophylaxis register improve tuberculosis contact management in South African children?
by: Nelda van Soelen, et al.
Published: (2013-01-01)

Isoniazid Prophylaxis of Latent Tuberculous Infection among Healthcare Workers in Bamrasnaradura Infectious Diseases Institute
by: Patama Suttha
Published: (2016-08-01)

Isoniazid Prophylaxis of Latent Tuberculous Infection among Healthcare Workers in Bamrasnaradura Infectious Diseases Institute
by: Patama Suttha, et al.
Published: (2016-07-01)

Response to <it>M. tuberculosis </it>selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study
by: Girardi Enrico, et al.
Published: (2008-01-01)

Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy
by: Allan W. Taylor, et al.
Published: (2013-01-01)

Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
by: Edward Chia-Cheng Lai, et al.
Published: (2021-09-01)

Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules
by: le Roux David M, et al.
Published: (2009-11-01)

Isoniazid Psychosis
by: U N Pathak, et al.
Published: (2003-01-01)

Isoniazid and alopecia
by: Somsri Wiwanitkit, et al.
Published: (2011-01-01)

Detection of genetic mutations in inh A and kat G for isoniazid and its association with rifampicin resistance in tuberculosis confirmed by line probe assay: Its rationality for isoniazid prophylaxis empirical or drug susceptibility testing guided
by: Prasanta Kumar Das, et al.
Published: (2019-01-01)

Isoniazid-induced alopecia
by: K B Gupta, et al.
Published: (2011-01-01)

Isoniazid metabolism and hepatotoxicity
by: Pengcheng Wang, et al.
Published: (2016-09-01)

Isoniazid and Pulmonary Fibrosis
by: Chae Uk Chung, et al.
Published: (2015-01-01)

Acute Isoniazid Neurotoxicity
by: J Gordon Millichap
Published: (1995-06-01)

Studies on the metabolism of isoniazid
by: 田培文
Published: (1987)

Assessing and screening for T-cell epitopes from Mycobacterium tuberculosis RD2 proteins for the diagnosis of active tuberculosis
by: Jiazhen Chen, et al.

Assessing and screening for T-cell epitopes from Mycobacterium tuberculosis RD2 proteins for the diagnosis of active tuberculosis
by: Jiazhen Chen, et al.
Published: (2018-11-01)

Immunological Responses and Epitope Mapping by Tuberculosis-Associated Antigens within the RD1 Region in Japanese Patients
by: Hideaki Nagai, et al.
Published: (2014-01-01)

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.
by: Raymund Dantes, et al.
Published: (2012-01-01)

Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan.
by: Tsai-Ling Liao, et al.
Published: (2016-01-01)

Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
by: Amlabu, Veronica Asibi
Published: (2014)

Cutaneous ichthyosis secondary to isoniazid
by: Hatim Kouismi, et al.
Published: (2013-04-01)

Isoniazid- and ethambutol-induced psychosis
by: Prasad R, et al.
Published: (2008-01-01)

The Effect of acetaminophen on isoniazid metabolism
by: Youssefi, Mohammed
Published: (2008)

Isoniazid resistance in Mycobacterium tuberculosis
by: Tho, Dau Quang
Published: (2012)

The Effect of acetaminophen on isoniazid metabolism
by: Youssefi, Mohammed
Published: (2008)

On the mechanism of the mycobacteriocidal action of isoniazid/
by: Shoeb, Hussein A.
Published: (1984)

Treating latent tuberculosis : Efficacy of rifapentine plus isoniazid combination therapy vs. isoniazid monotherapy
by: Khoury, Christinegie
Published: (2021)

Formulation of dispersible isoniazid/pyridoxine fixed-dose combination tablets for isoniazid preventive therapy in pediatrics
by: M. W. Mwangi, et al.
Published: (2020-01-01)

Results of anti-Toxoplasma gondii IgG, IgM, IgA and IgG Avidity testing in pregnant women in Rome, Italy
by: Carla Nisii, et al.
Published: (2012-12-01)

Resolution of RD/RD⁎ puzzle
by: Ashutosh Kumar Alok, et al.
Published: (2018-09-01)

Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.
by: Xiao Fang Lim, et al.
Published: (2012-01-01)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
by: Fabrizio Cantini, et al.
Published: (2017-01-01)

Polymorphism and structural studies of isoniazid derivatives
by: Hean, Duane
Published: (2015)

Pellagra in isoniazid preventive and antiretroviral therapy
by: John Koech Kipsang, et al.
Published: (2019-01-01)

Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)